Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Siemens Healthineers presents two revolutionary high-end MRI scanners for clinical and scientific use
Press release

Siemens Healthineers presents two revolutionary high-end MRI scanners for clinical and scientific use

Siemens Healthineers Shape 23 Press Conference 

Published on November 15, 2022

Image Gallery 

Terra.X Brain

Conventional 7T acquisition with clear signal loss in the lower part of the brain (left). 7T acquisition with Magnetom Terra.X1 and Ultra IQ Technology displaying improved homogeneity and coverage (right).
Download image

Download this press release

(pdf, 210.74 KB)
1Magnetom Terra.X is under development and is not commercially available. Future availability cannot be guaranteed.
2Magnetom Cima.X is under development and is not commercially available. Future availability cannot be guaranteed.
3Compared to other systems from Siemens Healthineers.
4Based on data acquired on Magnetom Cima.X. Data on file.
5>= 200 (+-3% for design tolerances)
6Huang, S. Y., Nummenmaa, A., Witzel, T., Duval, T., Cohen-Adad, J., Wald, L. L., & McNab, J. A. (2015). The impact of gradient strength on in vivo diffusion MRI estimates of axon diameter. NeuroImage, 106, 464–472. https://doi.org/10.1016/j.neuroimage.2014.12.008
7Open Recon is to add clinical reconstructions to the system, if signed and released for clinical use by SHS. Any other recon used e.g., by researchers is automatically labelled not for diagnostic use, which may require observation of national regulations.

Siemens Healthineers 2023

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion. Further information is available at www.siemens-healthineers.com.